Article
The molecular basis for the development of adult T-cell leukemia/lymphoma in patients with an IRF4K59R mutation.
Protein science : a publication of the Protein Society - 1 Apr 2022
Sundararaj Srinivasan, Seneviratne Sandali, Williams Simon J, Enders Anselm, Casarotto Marco G
Abstract excerpt
Interferon regulatory factor 4 (IRF4) is an essential regulator in the development of many immune cells, including B- and T-cells and has been implicated directly in numerous hematological malignancies, including adult T-cell leukemia/lymphoma (ATLL). Recently, an activating mutation in the DNA-binding domain of IRF4 (IRF4K59R ) was found as a recurrent somatic mutation in ATLL patients. However, it remains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
